Finlandia - finlandese - Fimea (Suomen lääkevirasto)

hexal a/s - sertraline hydrochloride - tabletti, kalvopäällysteinen - 100 mg - sertraliini

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - sertralinhydrochlorid - filmovertrukne tabletter - 50 mg

Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - sertralinehydrochloride 55,95 mg - eq. sertraline 50 mg - filmomhulde tablet - 50 mg - sertralinehydrochloride 55.95 mg - sertraline

Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - sertralinehydrochloride 111,9 mg - eq. sertraline 100 mg - filmomhulde tablet - 100 mg - sertralinehydrochloride 111.9 mg - sertraline

Austria - tedesco - AGES (Agentur für Gesundheit und Ernährungssicherheit)

krka - sertralin hydrochlorid - sertralin

Austria - tedesco - AGES (Agentur für Gesundheit und Ernährungssicherheit)

aristo pharma gmbh - sertralin hydrochlorid - sertralin

Austria - tedesco - AGES (Agentur für Gesundheit und Ernährungssicherheit)

aristo pharma gmbh - sertralin hydrochlorid - sertralin

Stati Uniti - inglese - NLM (National Library of Medicine)

remedyrepack inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - sertraline hydrochloride tablets are indicated for the treatment of the following [see clinical studies (14)] : - major depressive disorder (mdd) - obsessive-compulsive disorder (ocd) - panic disorder (pd) - posttraumatic stress disorder (ptsd) - social anxiety disorder (sad) - premenstrual dysphoric disorder (pmdd) sertraline hydrochloride tablets are contraindicated in patients: - taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)] . - taking pimozide [see drug interactions (7.1)] . - with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2)]. risk summary overall, available published epidemiologic studies of pregnant women exposed to sertraline in the first trimester suggest no difference in major birth defect risk compared to the background rate for major birth defects in compar

Stati Uniti - inglese - NLM (National Library of Medicine)

greenstone llc - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - sertraline hydrochloride is indicated for the treatment of the following [see clinical studies (14)] : sertraline hydrochloride is contraindicated in patients: in addition to the contraindications for all sertraline hydrochloride formulations listed above, sertraline hydrochloride oral solution is contraindicated in patients: risk summary overall, available published epidemiologic studies of pregnant women exposed to sertraline in the first trimester suggest no difference in major birth defect risk compared to the background rate for major birth defects in comparator populations. some studies have reported increases for specific major birth defects; however, these study results are inconclusive [see data] . there are clinical considerations regarding neonates exposed to ssris and snris, including sertraline hydrochloride, during the third trimester of pregnancy [see clinical considerations]. although no teratogenicity was observed in animal reproduction studies, delayed fetal ossification was observed when se

Stati Uniti - inglese - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - sertraline tablets, usp are indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action of sertraline in hospitalized depressed patients has not been adequately st